Sen. Corker makes his case for the GAIN Act.
Tennessee Republican Bob Corker’s GAIN Act has passed the Senate. As WPLN’s Nina Cardona reports, it’s a plan to spur development of new antibiotics that work on drug-resistant “superbugs.”
Corker calls the measure a way of improving health without spending federal dollars. It creates incentives for drug companies by extending the period before generics can go on the market and easing some of the red tape involved in the approval process.
Speaking on the Senate floor, Corker said it’s vital to develop the new drugs, and read a quote from a Memphis doctor.
“‘We don’t want to find ourselves in a situation in which we’ve been able to save a child’s life after cancer diagnosis only to lose them to an untreatable multidrug resistant infection.’”
The GAIN Act is part of the bill reauthorizing the Food and Drug Administration. Now that it’s passed the Senate, the measure is headed to the House of Representatives.
On Air - 90.3 WPLN-FM